Comparison of cardiac dysfunction in thalassemia major patients using deferoxamine or deferiprone as an iron-chelating agent

Comparison of cardiac dysfunction in thalassemia major patients using deferoxamine or deferiprone as an iron-chelating agent

Background In thalassemia major (TM) patients, major mortality is due to cardiac hemosiderosis. Several types of iron chelating agent available recently are given to overcome this problem Objective To compare cardiac dysfunction in thalassemia major patients who used subcutaneous deferoxamine (DFO)...

Full description

Bibliographic Details
Main Authors: Rosalina Josep, Pustika Amalia Wahidiiyat, Partini Trihono, Piprim Yanuarso
Format: Article
Language:English
Published: Indonesian Pediatric Society Publishing House 2012-10-01
Series:Paediatrica Indonesiana
Subjects:
thalassemia major
deferoxamine
deferiprone
diastolic dysfunction
systolic dysfunction
conventional echocardiography
TDI
Online Access:https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/473

Internet

https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/473

Similar Items